Platelet Glycoprotein IIb/IIIa Blockade in Acute Ischemic Stroke

By  

Cerebrovascular Diseases, Vol. 11, Iss. 4, 2001-05 ,pp. : 287-293

Karger

Access to resources Recommend Favorite

Glycoprotein IIb/IIIa Receptor Antagonists Inhibit the Development of Platelet Procoagulant Activity - Partial mapping of functionally significant glycoprotein IIIa epitopes

By Pedicord D.L.   Thomas B.E.   Mousa S.A.   Dicker I.B.  

Thrombosis Research, Vol. 90, Iss. 6, 1998-06 ,pp. : 247-258

Elsevier

Access to resources Recommend Favorite

Effects of platelet glycoprotein IIb-IIIa number and glycoprotein IIIa Leu33Pro polymorphism on platelet aggregation and sensitivity to glycoprotein IIb-IIIa antagonists

By Sirotkina Olga   Khaspekova Svetlana   Zabotina Anna   Shimanova Yulia   Mazurov Alexey  

Platelets, Vol. 18, Iss. 7, 2007-11 ,pp. : 506-514

Informa Healthcare

Access to resources Recommend Favorite

Effects of the glycoprotein IIb/IIIa antagonist Roxifiban on P-selectin expression, fibrinogen binding, and microaggregate formation in a phase I dose-finding study: no evidence for platelet activation during treatment with a glycoprotein IIb/IIIa antagonist

By Seiffert Dietmar   Thomas Beth E.   Bradley Jodi D.   Munzer Deborah A.   Tchinnes Maureen A.   Kornhauser David M.   Cain Valerie A.   Hua Tsuhung A.   Feuerstein Giora Z.   Martin David E.   Stern Andrew M.  

Platelets, Vol. 14, Iss. 3, 2003-05 ,pp. : 179-187

Informa Healthcare

Access to resources Recommend Favorite

Structural Biology of Glycoprotein IIb-IIIa

By Bennett J.S.  

Trends in Cardiovascular Medicine, Vol. 6, Iss. 1, 1996-01 ,pp. : 31-36

Elsevier

Access to resources Recommend Favorite